U.S. Water Utilities Stock News

NYSE:ONON
NYSE:ONONLuxury

On Holding (ONON) Margin Expansion To 7.8% Tests Premium 51x P/E Narrative

On Holding FY 2025 Results Set The Stage For A Margin Focused Year On Holding (NYSE:ONON) has just posted another quarterly update, with Q3 FY 2025 revenue at CHF 794.4 million and EPS at CHF 0.36, supported by trailing twelve month revenue of CHF 2.88 billion and EPS of CHF 0.68 that reflect earnings growth of 77.9% over the past year. The company has seen revenue move from CHF 2.32 billion to CHF 2.88 billion over the last twelve months, while EPS on a trailing basis has shifted from CHF...
NasdaqCM:GRRR
NasdaqCM:GRRRSoftware

Did Gorilla Technology Group's (GRRR) Sharply Narrowed 2025 Net Loss Just Shift Its Investment Narrative?

Gorilla Technology Group Inc. has released its full-year 2025 results, reporting sales of US$101.36 million versus US$74.67 million a year earlier and a net loss of US$11.28 million, compared with US$64.79 million previously. While the company remained loss-making, the sharp reduction in loss per share from US$6.13 to US$0.51 highlights a substantial improvement in its overall financial profile. We’ll now explore how this sharp reduction in annual net loss might influence Gorilla Technology...
NYSE:AMRC
NYSE:AMRCConstruction

Ameresco (AMRC) Earnings Show 2.3% Net Margin Squeezing Bullish Growth Narratives

Ameresco (AMRC) closed out FY 2025 with fourth quarter revenue of US$581 million and basic EPS of US$0.35, alongside net income of US$18 million. Over the past few quarters, the company has seen revenue move from US$353 million in Q1 2025 to US$472 million in Q2, US$526 million in Q3 and US$581 million in Q4. Basic EPS shifted from a loss of US$0.10 in Q1 to US$0.24 in Q2, US$0.35 in Q3 and US$0.35 again in Q4, setting up a results season where investors are likely to focus closely on how...
NYSE:GRND
NYSE:GRNDInteractive Media and Services

Grindr (GRND) Profitability Return Challenges Bearish Narratives Around Margin Pressure

Grindr FY 2025 earnings snapshot: profitability builds on higher revenue base Grindr (GRND) has wrapped up FY 2025 with Q4 revenue of US$126.0 million and basic EPS of US$0.11, with trailing twelve month revenue at US$439.9 million and EPS at US$0.51 as the company reports at a share price of US$11.32. The company has seen quarterly revenue move from US$97.6 million in Q4 2024 to US$126.0 million in Q4 2025, while basic EPS shifted from a loss of US$0.70 to a profit of US$0.11 over the same...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

Reassessing Power Solutions International (PSIX) After A Sharp Pullback And Strong Multi Year Rally

If you are wondering whether Power Solutions International is still attractively priced after its huge run, this article walks through what the current share price might be implying about value. The stock recently closed at US$60.91, with a 36.3% decline over the last 7 days and a 15.0% decline over 30 days, even though the 1 year return sits at 110.6% and the 3 year return is very large at over 20x. Recent coverage has focused on Power Solutions International's role as a provider of power...
NasdaqGS:ARHS
NasdaqGS:ARHSSpecialty Retail

Arhaus Special Dividend Highlights Capital Return Versus Growth Investment Trade Off

Arhaus (NasdaqGS:ARHS) has announced a special cash dividend to shareholders, an uncommon one off payout separate from any regular dividend. This decision highlights management’s current view of the company’s financial position and capital needs. The move directly affects shareholder cash returns and offers fresh insight into Arhaus’s capital allocation approach. Arhaus, trading at around $8.0 per share, has seen a 21.4% decline over the past month, a 29.6% decline year to date, and a 13.6%...
NYSE:BBWI
NYSE:BBWISpecialty Retail

Bath & Body Works Amazon Push And PEEPS Tie-Up Tested Against Valuation

Bath & Body Works launched an official Amazon store, expanding its products to a major third party marketplace. The company introduced a refreshed brand identity aimed at updating its look and feel for shoppers. Bath & Body Works also rolled out a spring collaboration with PEEPS, adding seasonal items to its assortment. Bath & Body Works, ticker NYSE:BBWI, is making these moves with its shares recently trading around $22.43. The stock shows mixed performance, with an 8.1% return year to...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

Is It Too Late To Reconsider Tradeweb Markets (TW) After Its Recent Share Price Rebound?

If you have been wondering whether Tradeweb Markets is priced fairly at its recent levels, this article walks through what the current market price might be telling you about its value. The stock last closed at US$125.61, with returns of 3.7% over the past week, 21.9% over the past month, 18.3% year to date, but a 5.5% decline over the past year, alongside gains of 76.9% over three years and 74.6% over five years. These mixed returns give you a snapshot of shifting sentiment toward Tradeweb...
NYSE:EDU
NYSE:EDUConsumer Services

Is New Oriental Education & Technology Group (EDU) Attractively Priced After Recent Share Price Weakness

If you are wondering whether New Oriental Education & Technology Group is attractively priced at its current level, you are not alone, the stock often raises questions about what you are really paying for. The share price closed at US$52.55, with returns of a 12.6% decline over 7 days, a 13.0% decline over 30 days, a 9.1% decline year to date, but a 15.4% gain over 1 year, a 34.4% gain over 3 years and a 71.1% decline over 5 years, a mix that can signal shifting views on growth and...
NYSE:TDW
NYSE:TDWEnergy Services

Tidewater (TDW) Q4 Margin Strength Challenges Bearish Earnings Decline Narrative

Tidewater FY 2025 earnings snapshot Tidewater (TDW) closed FY 2025 with Q4 revenue of US$336.8 million and basic EPS of US$4.44, with trailing twelve month revenue at about US$1.4 billion and EPS of US$6.69 setting the backdrop for this earnings season. The company reported quarterly revenue in the US$333 million to US$341 million range over FY 2025. Basic EPS moved from US$0.83 in Q1 to US$1.47 in Q2, then a small loss in Q3 and US$4.44 in Q4. Together with a higher trailing net margin, this...
NasdaqGS:DAKT
NasdaqGS:DAKTElectronic

Is It Too Late To Consider Daktronics (DAKT) After A 5x Three Year Surge?

Wondering if Daktronics at around US$24.88 is priced for what it is today or for a story that has already played out? This article is all about helping you frame that question through a clear valuation lens. The stock has been volatile recently, with a 9.0% decline over the last week, a 7.5% gain over the last month, a 25.4% return year to date, and a 73.6% return over the past year, on top of a very large 3-year gain of more than 5x. These moves sit against a backdrop of ongoing investor...
NYSE:LCII
NYSE:LCIIAuto Components

The Bull Case For LCI Industries (LCII) Could Change Following New Dividend, Buybacks And 2026 Guidance

LCI Industries recently approved a regular quarterly cash dividend of US$1.15 per share, following the release of its fourth-quarter and full-year 2025 results and new 2026 guidance, including expected revenue of US$4.20 billion to US$4.30 billion and operating profit margins of 7.5% to 8.0%. Together with an active acquisition pipeline and ongoing share repurchases totaling 1,060,916 shares since May 2025, these actions highlight the company’s focus on capital returns and growth through...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Tandem Diabetes Care Bond Deal Reshapes Funding And Valuation Picture

Tandem Diabetes Care completed a $265 million convertible bond offering, following a prior announcement of the transaction. The offering represents a significant capital markets move that directly affects the company’s financing profile and balance sheet. This funding event is separate from routine earnings or guidance updates and comes as the shares trade at $23.74 on NasdaqGM:TNDM. For you as an investor, the completed bond deal sits against a mixed share price backdrop for NasdaqGM:TNDM...
NYSE:ASB
NYSE:ASBBanks

Is Associated Banc-Corp (ASB) Attractive After Regional Banking Sector Reassessment?

If you are wondering whether Associated Banc-Corp is offering fair value right now, it helps to start by looking at what the recent share price is telling you about expectations and risk. The stock last closed at US$26.36, with returns of a 3.2% decline over 7 days, a 3.3% decline over 30 days, a 2.3% gain year to date, 16.5% over 1 year, 34.9% over 3 years and 46.5% over 5 years. This gives you a sense of how sentiment has shifted over different time frames. Recent news coverage has focused...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside

BeOne Medicines, listed as NasdaqGS:ONC, announced new collaborations with Amgen, Bristol Myers Squibb, and Novartis. The partnerships are focused on advancing BeOne Medicines' oncology therapy pipeline alongside its existing commercial products. The company also highlighted ongoing clinical trials that sit alongside these new pharma alliances. BeOne Medicines operates in oncology, an area where large pharma groups and smaller specialists often work together to bring new treatments through...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

How Investors Are Reacting To Kiniksa (KNSA) Turning ARCALYST Revenue Into Full-Year Profitability And Flexibility

Kiniksa Pharmaceuticals International, plc recently reported past fourth-quarter and full-year 2025 results, with revenue rising to US$202.13 million for the quarter and US$677.56 million for the year, alongside a swing from a prior net loss to net income of US$14.2 million and US$59.01 million respectively. The company also filed a US$149.83 million shelf registration for employee share offerings and is set to present at TD Cowen’s 46th Annual Health Care Conference, underscoring how...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

CHMP Setback Puts Acadia Rett Plans And Revenue Outlook In Focus

CHMP issued a negative opinion on ACADIA Pharmaceuticals' trofinetide marketing application for Rett syndrome in Europe. Acadia has requested a re examination of the opinion, triggering a formal review process. The decision affects prospects for European access to trofinetide and is drawing close attention from investors and patients. For investors watching NasdaqGS:ACAD, the regulatory setback comes with the stock trading around $22.5 and recent returns showing mixed signals. Shares are...
NYSE:UDR
NYSE:UDRResidential REITs

UDR CEO Conference Spotlight Links Dividend Story And Capital Priorities

UDR (NYSE:UDR) has announced that its Chairman, President & CEO will present at Citi’s Miami Global Property CEO Conference. The appearance follows the company’s release of new investor materials and regulatory filings. The conference slot is expected to focus on UDR’s current disclosures, capital allocation priorities, and portfolio positioning. UDR is a multifamily real estate investment trust focused on apartment communities, a segment that often sits at the intersection of housing...
NasdaqGS:ALGT
NasdaqGS:ALGTAirlines

Allegiant Travel Refocuses On Airline Core As Fleet Plan Faces Delays

Allegiant Travel (NasdaqGS:ALGT) is working through supply chain related delays affecting its Boeing 737 MAX fleet modernization. The company has completed the sale of its Sunseeker Resort, sharpening its focus on the core airline business. These developments are reshaping Allegiant Travel's operational plans and capital priorities in 2026. Allegiant Travel, known for its leisure focused, low frequency route network, is refocusing on its airline operations as aircraft deliveries face timing...
NYSE:DTM
NYSE:DTMOil and Gas

Is DT Midstream (DTM) Still Attractive After A 56% One Year Share Price Surge

If you are wondering whether DT Midstream's share price still offers fair value after a strong run, this article will walk through what the current valuation numbers actually say. The stock last closed at US$140.66, with returns of 2.5% over 7 days, 11.6% over 30 days, 16.3% year to date and 55.6% over the past year. These figures naturally raise questions about how much of the story is already priced in. Recent coverage has focused on DT Midstream's position as a key energy infrastructure...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Teradyne’s 5G Open RAN Push Meets Lofty Valuation Expectations

Teradyne (NasdaqGS:TER) is working with LitePoint, Aethertek, and Metanoia to develop next-generation 5G FR2 Open Radio Units for global Open RAN deployments. The collaboration focuses on test, verification, and commercialization of these O-RUs ahead of a planned live demonstration at Mobile World Congress 2026. The partners aim to support equipment vendors and operators as they roll out higher frequency 5G infrastructure using open network architectures. Teradyne is best known for its...
NYSE:ENVA
NYSE:ENVAConsumer Finance

How Investors May Respond To Enova International (ENVA) Inflation Jitters And Interest Rate Uncertainty

In the past week, financial technology company Enova International was caught in a broader sell-off in financial stocks after a hotter-than-expected US Producer Price Index reading raised concerns about persistent inflation and the Federal Reserve’s limited scope to lower interest rates soon. Despite this macro-driven pressure, Enova’s longer-term performance, including very large multi-year stock gains and consistent revenue and earnings growth, has kept market attention on how its business...
NasdaqGS:LMRI
NasdaqGS:LMRIHealthcare

A Look At Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Strength

Event-driven snapshot of Lumexa Imaging Holdings Lumexa Imaging Holdings (LMRI) has attracted fresh attention after recent price moves, with the stock showing a 7.5% return over the past week and a 26.3% gain over the past month. At a last close of US$15.47 and a year-to-date return of an 11.9% decline, investors are weighing those market moves against annual revenue of US$1,003.38m and a reported net loss of US$43.47m. See our latest analysis for Lumexa Imaging Holdings. That recent 26.3% 1...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Arch Capital Group Weighs Record 2025 Results Against Capital Return Potential

Arch Capital Group (NasdaqGS:ACGL) reported record financial performance for 2025, supported by strong results in its Reinsurance and Mortgage segments. The company outlined a capital plan that could return nearly all generated capital to shareholders if attractive growth opportunities are limited. Management highlighted segment contributions and capital allocation as key themes for the 2025 performance update. For investors watching Arch Capital Group at a share price of $100.48, the...